KRAS and Patent ductus arteriosus: Although some studies have demonstrated that mut-KRAS detection, concentration, and MAF can provide insight into outcomes and treatment responses in patients with PDA, other larger studies and meta-analyses have indicated the importance of other mutations [27,28,75,77,85,86].